Emerging β-amyloid pathology and accelerated cortical atrophy.
about
Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsMagnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's DiseaseMapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.The evolution of preclinical Alzheimer's disease: implications for prevention trials.Brain structure and function as mediators of the effects of amyloid on memory.The transitional association between β-amyloid pathology and regional brain atrophyIncreased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models.Accelerated decline in white matter integrity in clinically normal individuals at risk for Alzheimer's diseaseProgressively Disrupted Intrinsic Functional Connectivity of Basolateral Amygdala in Very Early Alzheimer's Disease.Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information.Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.Early-Onset Alzheimer Disease.Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years PriorEarliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
P2860
Q26827219-5FC22BC8-808C-4940-88D9-A6D713BB9DBEQ26830467-C05844F7-3216-4D5F-8425-75FA6AB6B51EQ30981669-E5A83F54-A267-4386-8A2A-8787DD86A845Q33695122-C0AC39D0-E0D0-4798-B2A0-F139253267DAQ34498348-986D45A1-740D-4DBF-B8BF-5A85E050B1EEQ34849048-A658F0D1-EC90-4356-97AA-ACFB8E4BA372Q35211063-5AC0C31C-9691-4225-A96C-69D4C9F0EFC7Q35706871-3E0A5E67-0345-4ADB-A6C2-F66C92AAFA2BQ35904243-E38E1654-E509-4D15-800A-EB3C5A0E9635Q36870947-CEC20722-213B-455F-9310-3416F48E8D58Q37263551-0EC0EEF2-5F8B-42A8-81FA-0AE9DD89597AQ37303038-266704D4-D8EB-4CBF-B064-464B0C5C6080Q37307467-A344C3AF-F1BD-4040-B110-981A9E07F743Q39243357-C8F596B9-7FFA-488C-8B6A-40A011ED18C9Q39929112-205D0A1A-613A-4E06-AA30-FCF9E68933B5Q42643417-1FCD97FB-C0AB-42CE-B702-E7E0D4BC06B2Q42858923-D403AC89-AD40-45CB-BAA4-887DA03845AFQ46045880-B7E4484C-A4D4-4B10-A972-9C2BF6FD037DQ47574138-B45432D7-0023-480A-8381-A7E6506A26C6Q52630015-D05644E8-6023-4DAB-BF0D-E5FF851AFDD6Q59128613-0A14D7E0-14C7-4BA9-9EBB-FD9AB0894419
P2860
Emerging β-amyloid pathology and accelerated cortical atrophy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Emerging β-amyloid pathology and accelerated cortical atrophy.
@ast
Emerging β-amyloid pathology and accelerated cortical atrophy.
@en
type
label
Emerging β-amyloid pathology and accelerated cortical atrophy.
@ast
Emerging β-amyloid pathology and accelerated cortical atrophy.
@en
prefLabel
Emerging β-amyloid pathology and accelerated cortical atrophy.
@ast
Emerging β-amyloid pathology and accelerated cortical atrophy.
@en
P2093
P2860
P50
P1433
P1476
Emerging β-amyloid pathology and accelerated cortical atrophy.
@en
P2093
Duygu Tosun
Leslie M Shaw
Michael C Donohue
Philip S Insel
Rachel Nosheny
P2860
P304
P356
10.1001/JAMANEUROL.2014.446
P407
P50
P577
2014-06-01T00:00:00Z